首页> 外文学位 >THE INTERACTION OF IMMUNE COMPLEXES WITH RBC AND PHAGOCYTIC CELLS (RED BLOOD CELLS, COMPLEMENT, ANTIBODY, ERYTHROCYTES, MONOCYTE, ANTIGEN).
【24h】

THE INTERACTION OF IMMUNE COMPLEXES WITH RBC AND PHAGOCYTIC CELLS (RED BLOOD CELLS, COMPLEMENT, ANTIBODY, ERYTHROCYTES, MONOCYTE, ANTIGEN).

机译:免疫复合物与RBC和吞噬细胞(红血细胞,补体,抗体,红细胞,单核细胞,抗原)的相互作用。

获取原文
获取原文并翻译 | 示例

摘要

In our studies, we started by examining the interaction of surface-bound immune complexes (IC) with PMN leukocytes, placing particular emphasis on the release of platelet activating factor (PAF). Having proved that insoluble and immobilized soluble IC trigger the release of PAF from PMN leukocytes and that insoluble IC stimulate interleukin 1 (IL 1) release from monocytes, we proceeded to study whether IC adsorbed to human erythrocytes (RBC) would induce the same effects. Having concluded that such was the case, we studied the conditions that surround RBC-IC interactions as well as the fate of RBC-bound IC and of the RBC themselves after interaction with phagocytic cells.;In Chapter II we describe our studies concerning immune complex binding to RBC. We initially observed that heat aggregated gamma globulin bound readily to HRBC, even under conditions excluding complement mediated activity. In addition, soluble IC (particularly when prepared at antigen excess) were capable of binding to HRBC in vitro in absence of complement. Further investigations determined that the antigens (tetanus toxoid and hemocyanin) used in the preparation of soluble IC at antigen excess were themselves capable of in vitro adsorption to HRBC.;In Chapter III we describe our studies on the interaction of soluble TT-ATT IC adsorbed onto HRBC with PMN leukocytes and monocytes. Our studies were focused on: (1) the fate of IC and (2) the fate of the red cells themselves.;Another set of experiments was designed to study the activation capacity of IC-HRBC interactions with PMN or monocytes, measuring the release of PAF and IL 1, respectively. (Abstract shortened with permission of author.).;Chapter I describes our studies of the interactions between soluble tetanus toxoid-rabbit antitetanus toxoid (TT-ATT) IC, insoluble TT-ATT IC, and surface-bound IC with PMN leukocytes in which the in vitro release of PAF was the principal activation parameter measured. Our results indicated that insoluble IC and surface bound IC stimulated substantial PAF release from PMN leukocytes; in contrast, soluble IC proved to be very poor stimuli of PAF release.
机译:在我们的研究中,我们从检查表面结合的免疫复合物(IC)与PMN白细胞的相互作用开始,特别强调血小板活化因子(PAF)的释放。已经证明不溶性和固定化的可溶性IC会触发PMN白细胞释放PAF,并且不溶性IC会刺激单核细胞释放白介素1(IL 1),我们着手研究IC吸附到人红细胞(RBC)上是否会产生相同的作用。在得出结论的情况下,我们研究了围绕RBC-IC相互作用的条件,以及与吞噬细胞相互作用后RBC结合的IC和RBC本身的命运。在第二章中,我们描述了关于免疫复合物的研究绑定到RBC。我们最初观察到,即使在排除补体介导的活性的条件下,热聚集的γ球蛋白也容易与HRBC结合。此外,可溶性IC(尤其是在抗原过量时制备)在体外不存在补体的情况下能够与HRBC结合。进一步的研究确定,在抗原过量时用于制备可溶性IC的抗原(破伤风类毒素和血蓝蛋白)本身具有体外吸附到HRBC的能力。 PMN白细胞和单核细胞转移到HRBC上。我们的研究重点是:(1)IC的命运和(2)红细胞本身的命运。;设计了另一组实验,以研究IC-HRBC与PMN或单核细胞相互作用的激活能力,测量释放分别为PAF和IL 1。第一章描述了我们对可溶性破伤风类毒素-兔抗破伤风类毒素IC,不溶性TT-ATT IC和表面结合IC与PMN白细胞之间相互作用的研究,其中PAF的体外释放是测量的主要激活参数。我们的结果表明,不溶性IC和表面结合IC刺激了PMN白细胞中大量PAF的释放。相反,可溶性IC被证明对PAF释放的刺激非常差。

著录项

  • 作者

    SHERWOOD, THOMAS ALLEN.;

  • 作者单位

    Medical University of South Carolina.;

  • 授予单位 Medical University of South Carolina.;
  • 学科 Microbiology.;Immunology.
  • 学位 Ph.D.
  • 年度 1985
  • 页码 117 p.
  • 总页数 117
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号